One expert applauded the new study.
"They have debunked the commonly held belief that age alone is a risk factor for recurrence after treatment of DCIS," said Dr. Ann Partridge, a medical oncologist and researcher at the Dana-Farber Cancer Institute and Brigham and Women's Hospital, in Boston.
Partridge has published about women's anxiety over their prognosis when diagnosed with a DCIS. She found that women are typically highly anxious, even though their risk of recurrence or of developing invasive breast cancer is low.
"I think this is a good study," Partridge said, although it does have limitations. For instance, she said, it is a single-institution study. However, Fox Chase physicians "are doing what they should be doing," Partridge said, explaining that the institution is careful about selecting the right treatment for the right patients, based on the characteristics of their cancer.
There's more on DCIS at breastcancer.org.
SOURCES: Aruna Turaka, M.D., fellow, department of radiation oncology, Fox Chase Cancer Center, Philadelphia; Ann Partridge, M.D., medical oncologist and researcher, Dana-Farber Cancer Institute and Brigham & Women's Hospital, Boston; Sept. 24, 2008, presentation, American Society for Therapeutic Radiology and Oncology annual meeting, Boston
All rights reserved